The AST handbook of transplant infections
https://libcat.nshealth.ca/en/permalink/provcat25634
edited by Deepali Kumar, Atul Humar [...] ; on behalf of the American Society of Transplantation Infectious Diseases Community of Practice.
--West Sussex, England:
Wiley-Blackwell
, 2011.
- Call Number
- WO 660 A852 2011
- Location
- Dickson Building
- Call Number
- WO 660 A852 2011
- Other Authors
- Kumar, Deepali
- Humar, Atul
- Responsibility
- edited by Deepali Kumar, Atul Humar [...] ; on behalf of the American Society of Transplantation Infectious Diseases Community of Practice
- Place of Publication
- West Sussex, England
- Publisher
- Wiley-Blackwell
- Date of Publication
- 2011
- Physical Description
- xv, 171 p.
- ISBN
- 9780470658277
- 0470658274
- Subjects (MeSH)
- Communicable Disease Control
- Immunosuppressive agents - adverse effects
- Postoperative Complications - prevention & control
- Bacterial Infections - therapy
- Mycoses - therapy
- Virus Diseases - therapy
- Subjects (LCSH)
- Communicable diseases--Handbooks, manuals, etc
- Transplantation of organs, tissues, etc.--Complications--Handbooks, manuals, etc
- Format
- Book
- Publication Type
- Handbook
- Location
- Dickson Building
- Loan Period
- 3 weeks
Azathioprine and Mercaptopurine Therapy
https://libcat.nshealth.ca/en/permalink/chpams35565
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program.
Halifax, NS:
Nova Scotia Health Authority
, 2021.
- Pamphlet Number
- 1079
- Available Online
- View Pamphlet
This pamphlet will help you decide if azathioprine (Imuran®) or mercaptopurine therapy is right for you. The pamphlet explains what azathioprine (AZA) and mercaptopurine (6-MP) are, how well they work, as well as serious and less serious side-effects. The pamphlet also includes a list of what you can do to lower the chances of side-effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.): digital, PDF file
- Subjects (MeSH)
- Immunosuppressive Agents
- Azathioprine
- Mercaptopurine
- Subjects (LCSH)
- Immunosuppressive agents
- Specialty
- Medications
- Abstract
- This pamphlet will help you decide if azathioprine (Imuran®) or mercaptopurine therapy is right for you. The pamphlet explains what azathioprine (AZA) and mercaptopurine (6-MP) are, how well they work, as well as serious and less serious side-effects. The pamphlet also includes a list of what you can do to lower the chances of side-effects.
- Notes
- Previous title: Azathioprine (Imuran) therapy
- Responsibility
- Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Pamphlet Number
- 1079
Azathioprine (Imuran and generic brands) and 6-MP (Purinethol and generic brands)
https://libcat.nshealth.ca/en/permalink/chpams37707
IWK. Gastroenterology, Nutrition & Paediatric Health Psychology Team, IWK. Pediatric Medical Services.
Halifax, NS:
IWK Health Centre
, 2019.
- Pamphlet Number
- PL-0204
- Available Online
- View Pamphlet
Information about Azathioprine (Imuran) and 6-MP (Purinethol) for patients and families.
- Available Online
- View Pamphlet
- Corporate Author
- IWK. Gastroenterology, Nutrition & Paediatric Health Psychology Team
- IWK. Pediatric Medical Services
- Alternate Title
- A Patient Guide
- Place of Publication
- Halifax, NS
- Publisher
- IWK Health Centre
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document : digital, PDF file
- Subjects (MeSH)
- Immunosuppressive Agents
- Subjects (LCSH)
- Immunosuppressive agents
- Abstract
- Information about Azathioprine (Imuran) and 6-MP (Purinethol) for patients and families.
- Responsibility
- IWK Gastroenterology, Nutrition & Paediatric Health Psychology Team, Halifax, NS
- Pamphlet Number
- PL-0204
Chronic graft versus host disease : interdisciplinary management
https://libcat.nshealth.ca/en/permalink/provcat27729
Vogelsang, Georgia B.
--Cambridge:
Cambridge University Press
, 2009.
- Available Online
- View e-Book
- Location
- Online
- Available Online
- View e-Book
- Author
- Vogelsang, Georgia B
- Other Authors
- Pavletic, Steven Z
- Place of Publication
- Cambridge
- Publisher
- Cambridge University Press
- Date of Publication
- 2009
- Physical Description
- 422 p.
- Series Title
- Cambridge medicine
- ISBN
- 9780511576751 (ebook)
- Subjects (MeSH)
- Graft vs Host Disease - therapy
- Chronic Disease - therapy
- Immunosuppression
- Immunosuppressive Agents
- Format
- e-Book
- Location
- Online
Cytomegalovirus (CMV)
https://libcat.nshealth.ca/en/permalink/chpams36606
Nova Scotia Health Authority. Kidney Transplant Clinic.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 1999
- Available Online
- View Pamphlet
The cytomegalovirus (CMV) is a common virus found in people of all ages. People who have had a kidney transplant and are taking immunosuppressive medications are at risk. The pamphlet outlines the symptoms, how the virus is diagnosed, and how it is treated.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Kidney Transplant Clinic
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([1] p.) : digital, PDF file
- Subjects (MeSH)
- Cytomegalovirus
- Kidney Transplantation - adverse effects
- Immunosuppressive Agents - adverse effects
- Specialty
- Nephrology
- Medications
- Abstract
- The cytomegalovirus (CMV) is a common virus found in people of all ages. People who have had a kidney transplant and are taking immunosuppressive medications are at risk. The pamphlet outlines the symptoms, how the virus is diagnosed, and how it is treated.
- Responsibility
- Prepared by: Kidney Transplant Clinic
- Pamphlet Number
- 1999
Immune modulation and anti-inflammatory therapy in ocular disorders : IOIS guidelines
https://libcat.nshealth.ca/en/permalink/provcat34026
Uwe Pleyer, Jorge L. Alió, Talin Barisani-Asenbauer, Phuc Le Hoang, Narsing A. Rao, editors.
--Heidelberg:
Springer
, c2014.
- Available Online
- View e-Book
- Location
- Online
These guidelines, compiled by a panel of clinicians and scientists with a high level of expertise, aim to provide readers with the most up-to-date and comprehensive instructions on the treatment and prevention of ocular inflammation. All of the recommendations are explicitly linked to supporting evidence and graded according to the strength of that evidence, and the editors have made every effort to ensure that chapters are of a consistently high methodological quality. The guidelines for each …
- Available Online
- View e-Book
- Corporate Author
- International Ocular Inflammation Society
- Other Authors
- Pleyer, Uwe
- Responsibility
- Uwe Pleyer, Jorge L. Alió, Talin Barisani-Asenbauer, Phuc Le Hoang, Narsing A. Rao, editors
- Place of Publication
- Heidelberg
- Publisher
- Springer
- Date of Publication
- c2014
- Physical Description
- 1 online resource (xiii, 244 pages)
- ISBN
- 9783642543500 (electronic bk.)
- 9783642543494
- Subjects (MeSH)
- Eye Diseases - immunology
- Immunomodulation - drug effects
- Immunosuppression - methods
- Immunosuppressive Agents - therapeutic use
- Inflammation - drug therapy
- Subjects (LCSH)
- Eye - Diseases
- Eye - Diseases - Immunological aspects
- Abstract
- These guidelines, compiled by a panel of clinicians and scientists with a high level of expertise, aim to provide readers with the most up-to-date and comprehensive instructions on the treatment and prevention of ocular inflammation. All of the recommendations are explicitly linked to supporting evidence and graded according to the strength of that evidence, and the editors have made every effort to ensure that chapters are of a consistently high methodological quality. The guidelines for each treatment include dose and the frequency and mode of delivery. Significant side-effects of treatment are identified and distinguished from those of the disease in question. Suggestions are presented for the prevention both of the disease itself and of the treatment-related complications. In addition, likely future directions in treatment and prevention are identified.
- Contents
- Ocular Allergy -- Immune Modulation in Ocular Mucous Membrane Pemphigoid -- Diagnosis and Management of Scleritis -- Noninfectious Inflammation in Cataract Surgery -- Corneal Inflammation Following Excimer Laser Surgery -- Prevention and Treatment of Transplant Rejection in Keratoplasty -- Immunomodulation Against Inflammatory Postkeratoplasty Neovascularisation -- Treatment of Inflammation Secondary to Vitreoretinal Surgery -- Treatment of Intermediate Uveitis -- Posterior Uveitis -- Cystoid Macular Edema -- Safety of Immunosuppressive Therapy for Eye Diseases.
- Format
- e-Book
- Location
- Online
Infections in solid-organ transplant recipients
https://libcat.nshealth.ca/en/permalink/provcat23550
Alangaden, George J.
American Society for Microbiology.
--Washington, DC:
ASM Press
, c2008.
- Call Number
- WC 195 I43 2008
- Location
- Halifax Infirmary
- Call Number
- WC 195 I43 2008
- Author
- Alangaden, George J
- Corporate Author
- American Society for Microbiology
- Place of Publication
- Washington, DC
- Publisher
- ASM Press
- Date of Publication
- c2008
- Physical Description
- 63 p.
- Series Vol.
- 45
- Series Title
- Cumitech
- ISBN
- 9781555814496
- Subjects (MeSH)
- Organ Transplantation
- Opportunistic Infections
- Cross Infection
- Immunosuppressive Agents - adverse effects
- Format
- Book
- Location
- Halifax Infirmary
- Copies
- 2
- Loan Period
- 3 weeks
Methotrexate (MTX) therapy for inflammatory bowel disease (IBD)
https://libcat.nshealth.ca/en/permalink/chpams34942
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program.
Halifax, NS:
Nova Scotia Health Authority
, 2021.
- Pamphlet Number
- 1138
- Available Online
- View Pamphlet
Your health care provider feels that treatment with methotrexate (meth-oh-TREX-ate) might help your Crohn’s disease or ulcerative colitis. These are both types of inflammatory bowel disease (IBD). This pamphlet explains what methotrexate (MTX) is, how well it works, side effects of MTX, who should not take MTX, and precautions. Instructions for injecting MTX are given.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (13 p.) : digital, PDF file
- Specialty
- Gastrointestinal System
- Medications
- Abstract
- Your health care provider feels that treatment with methotrexate (meth-oh-TREX-ate) might help your Crohn’s disease or ulcerative colitis. These are both types of inflammatory bowel disease (IBD). This pamphlet explains what methotrexate (MTX) is, how well it works, side effects of MTX, who should not take MTX, and precautions. Instructions for injecting MTX are given.
- Responsibility
- Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Pamphlet Number
- 1138
Meyler's side effects of drugs used in cancer and immunology
https://libcat.nshealth.ca/en/permalink/provcat32091
editor, J.K. Aronson.
--Amsterdam ; London:
Elsevier Science
, c2010.
- Available Online
- View e-Book
- Access
- Registration required for PDF access.
- Location
- Online
Elsevier now offers a series of derivative works based on the acclaimed Meyler's Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician.
- Available Online
- View e-Book
- Other Authors
- Aronson, J. K
- Meyler, L
- Responsibility
- editor, J.K. Aronson
- Alternate Title
- Side effects of anticancer drugs
- Place of Publication
- Amsterdam ; London
- Publisher
- Elsevier Science
- Date of Publication
- c2010
- Physical Description
- 1 online resource (viii, 774 p.)
- ISBN
- 9780444532671 (hbk.)
- Subjects (MeSH)
- Antineoplastic Agents - adverse effects
- Adjuvants, Immunologic - adverse effects
- Immunosuppressive agents - adverse effects
- Drug Interactions
- Subjects (LCSH)
- Cytostatic Agents - adverse effects
- Anti-Allergic Agents - adverse effects
- Drugs - Side effects
- Cancer - Chemotherapy - Complications
- Abstract
- Elsevier now offers a series of derivative works based on the acclaimed Meyler's Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician.
- Access
- Registration required for PDF access.
- Format
- e-Book
- Location
- Online
Polyoma virus and BK virus
https://libcat.nshealth.ca/en/permalink/chpams35425
Nova Scotia Health Authority. Kidney Transplant Clinic.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1510
- Available Online
- View Pamphlet
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of …
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Kidney Transplant Clinic
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Polyomavirus
- BK Virus
- Kidney Transplantation - adverse effects
- Immunosuppressive Agents - adverse effects
- Subjects (LCSH)
- Polyomaviruses
- Kidneys--Transplantation
- Immunosuppressive agents
- Specialty
- Nephrology
- Medications
- Abstract
- BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of BK virus, how BK virus is diagnosed, and how it is treated.
- Responsibility
- Prepared by: Kidney Transplant Clinic
- Pamphlet Number
- 1510
Skin disease in organ transplantation
https://libcat.nshealth.ca/en/permalink/provcat23548
Otley, Clark C.
--Cambridge, England:
Cambridge University Press
, 2008.
- Call Number
- WR 140 S628 2008
- Location
- Dickson Building
- Call Number
- WR 140 S628 2008
- Author
- Otley, Clark C
- Other Authors
- Stasko, Thomas
- Place of Publication
- Cambridge, England
- Publisher
- Cambridge University Press
- Date of Publication
- 2008
- Physical Description
- 353 p.
- ISBN
- 9780521870672
- Subjects (MeSH)
- Skin Diseases
- Organ Transplantation - adverse effects
- Immunosuppressive Agents - adverse effects
- Format
- Book
- Location
- Dickson Building
- Loan Period
- 3 weeks
Skin diseases in the immunocompromised
https://libcat.nshealth.ca/en/permalink/provcat34055
John C. Hall, editor.
--London:
Springer
, c2014.
- Available Online
- View e-Book
- Location
- Online
As the number of surviving immune suppressed patients continues to rise, skin manifestations of patients have become increasingly important. AIDS patients, and renal, heart, liver, bone marrow, and lung transplant patients are now living longer and immunosuppressive drugs are being used more frequently. Diabetes is rising in the US and around the world, offering its own unique brand of immune suppressed skin diseases. The skin may be the earliest sign of these conditions and be the organ showin…
- Available Online
- View e-Book
- Other Authors
- Hall, John C.
- Responsibility
- John C. Hall, editor
- Place of Publication
- London
- Publisher
- Springer
- Date of Publication
- c2014
- Physical Description
- 1 online resource (xvi, 191 pages)
- ISBN
- 9781447164791 (electronic bk.)
- 9781447164784
- Subjects (MeSH)
- Immunocompromised Host
- Immunosuppressive agents - adverse effects
- Radiotherapy - adverse effects
- Skin Diseases - immunology
- Transplantation Immunology
- Subjects (LCSH)
- Skin - Diseases
- Immunologic diseases
- Dermatology
- Infectious Diseases
- Abstract
- As the number of surviving immune suppressed patients continues to rise, skin manifestations of patients have become increasingly important. AIDS patients, and renal, heart, liver, bone marrow, and lung transplant patients are now living longer and immunosuppressive drugs are being used more frequently. Diabetes is rising in the US and around the world, offering its own unique brand of immune suppressed skin diseases. The skin may be the earliest sign of these conditions and be the organ showing the most profound, earliest, and treatment limiting side effects. Skin Diseases in the Immunocompromised is the most comprehensive book on the topic available. It elucidates the signs of immune suppressed skin diseases to afford early diagnosis and management of this ever-increasing diverse group of illnesses.
- Contents
- Part I. Disease Specific -- Skin Disorders in Immunocompromised Diabetes Patients -- Skin Disorders of AIDS Patients -- Skin Disorders in Patients with Primary Immunodeficiencies -- Cancer Patients and Skin Disease -- Part II. Transplant Patients -- Skin Disease in Solid Organ Transplant Patients -- Graft vs Host Disease and Skin Manifestations -- Part III. Drug Related -- Cutaneous Reactions to the Biologics -- Cutaneous Reactions to Chemotherapy -- Cutaneous Reactions to Corticosteroids -- Cutaneous Reactions to Tyrosine Kinase Inhibitors -- Part IV. Age Related -- Cutaneous Manifestations of Aging and Immunodeficiency -- Part V. Radiation -- UVA and UVB Therapy: Practical Applications and Implications for the Immunosuppressed Patient and Skin Disease -- Skin Cancer in the Immunocompromised -- Radiation Therapy for Non-melanoma Skin Cancer in Immunosuppressed Patients and Cutaneous Toxicity from This Therapy.
- Format
- e-Book
- Location
- Online
Skin Diseases in the Immunosuppressed
https://libcat.nshealth.ca/en/permalink/provcat42882
edited by Oscar R. Colegio.
--Cham, Switzerland:
Springer
, c2018.
- Available Online
- View e-Book
- Location
- Online
In this book, expert dermatologists review state of the art knowledge concerning the clinical presentation and management of cutaneous diseases that develop in immunosuppressed individuals, including transplant recipients, those with primary immunodeficiencies, and HIV sufferers. Throughout the book, correlations are made with iatrogenic, primary, and acquired immunodeficiencies. A major aim is to enable dermatologists to identify the specific immunosuppressant responsible for a specific advers…
- Available Online
- View e-Book
- Other Authors
- Colegio, Oscar R.
- Responsibility
- edited by Oscar R. Colegio
- Place of Publication
- Cham, Switzerland
- Publisher
- Springer
- Date of Publication
- c2018
- Physical Description
- 1 online resource (x, 211 p.) : 49 illus. in color
- ISBN
- 9783319687902
- 9783319687889 (print ed.)
- 9783319687896 (print ed.)
- Subjects (MeSH)
- Immunocompromised Host
- Immunosuppressive Agents - adverse effects
- Radiotherapy - adverse effects
- Skin Diseases
- Transplantation Immunology
- Specialty
- Allergy and Immunology
- Dermatology
- Abstract
- In this book, expert dermatologists review state of the art knowledge concerning the clinical presentation and management of cutaneous diseases that develop in immunosuppressed individuals, including transplant recipients, those with primary immunodeficiencies, and HIV sufferers. Throughout the book, correlations are made with iatrogenic, primary, and acquired immunodeficiencies. A major aim is to enable dermatologists to identify the specific immunosuppressant responsible for a specific adverse effect, whether benign or malignant, in patients receiving a complex medication regimen in the setting of transplantation. Further, the book will help the dermatologist to distinguish the cutaneous adverse effects of antiviral agents from effects arising directly from advancing HIV disease. Recognition of the cutaneous manifestations of often less common primary immunodeficiencies will also be emphasized. A final goal is to improve patient outcomes by providing dermatologists with treatment strategies for skin disease arising in the immunosuppressed state. This book will be invaluable for a broad audience, from practicing dermatologists to medical and dermatology residents.
- Contents
- The Immune System: Structure, Function, and Roles in Skin Disease -- Skin Diseases in Primary Immunodeficiencies -- Skin Diseases Associated with HIV Disease -- Benign Cutaneous Eruptions After Transplantation -- Cutaneous Malignancies in Solid Organ Transplant Recipients -- Skin Diseases Associated with Stem Cell Transplantation -- Skin Cancers Associated With Lymphoid Malignancies -- Skin Diseases Associated with Biologic Therapies -- Virally Induced Cancers -- Immunosenescence and Cutaneous Malignancies.
- Format
- e-Book
- Location
- Online
